International Isotopes gets go-ahead

Article

Radioisotope manufacturer International Isotopes of Denton, TX, reported last month that the Texas Department of Public Health's Bureau of Radiation Control has approved a license amendment for the production of small quantities of thallium-201, a

Radioisotope manufacturer International Isotopes of Denton, TX, reported last month that the Texas Department of Public Health's Bureau of Radiation Control has approved a license amendment for the production of small quantities of thallium-201, a radioisotope used for the diagnosis of heart disease and cardiac function. The isotope will be manufactured using International Isotopes' linear accelerator, as well as its cyclotron.

The approval allows the firm to begin preliminary shipments of thallium and other radiochemicals to pharmaceutical companies, a crucial step in establishing itself as a reliable provider of raw pharmaceutical material, according to Carl Seidel, president and CEO. International Isotopes will begin shipping thallium in early March, but declined to name particular customers.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.